When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Cutaneous B-cell lymphoma - Wikipedia

   en.wikipedia.org/wiki/Cutaneous_B-cell_lymphoma

   Primary cutaneous diffuse large B-cell lymphoma, leg type is an aggressive B-cell lymphoma that is often resistant to therapy and carries a poor prognosis, [5] i.e., they have a 5-year disease-specific survival rate of 43% or 70% depending on whether their cancer cells have or do not have, respectively, inactivating mutations in both of their ...

3. Non-Hodgkin lymphoma - Wikipedia

   en.wikipedia.org/wiki/Non-Hodgkin_lymphoma

   Non-Hodgkin lymphoma (NHL), also known as non-Hodgkin's lymphoma, is a group of blood cancers that includes all types of lymphomas except Hodgkin lymphomas. [1] Symptoms include enlarged lymph nodes, fever, night sweats, weight loss, and tiredness. [1] Other symptoms may include bone pain, chest pain, or itchiness. [1]

4. B-cell lymphoma - Wikipedia

   en.wikipedia.org/wiki/B-cell_lymphoma

   Micrograph showing Hodgkin's lymphoma, a type of B cell lymphoma that is usually considered separate from other B cell lymphomas. Field stain. CT scan of primary B cell lymphoma in the left ilium, as diffuse cortical and trabecular thickening of the hemipelvis, mimicking Paget's disease. [2] There are numerous kinds of lymphomas involving B cells.

5. Tumors of the hematopoietic and lymphoid tissues - Wikipedia

   en.wikipedia.org/wiki/Tumors_of_the...

   The use of rituximab has been established for the treatment of B-cell–derived hematologic malignancies, including follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). [ 7 ] In addition to cure-directed treatment, people can benefit from self-care to manage symptoms.

6. Ibritumomab tiuxetan - Wikipedia

   en.wikipedia.org/wiki/Ibritumomab_tiuxetan

   Ibritumomab tiuxetan is used to treat relapsed or refractory, low grade or transformed B cell non-Hodgkin's lymphoma (NHL), a lymphoproliferative disorder, and previously untreated follicular NHL in adults who achieve a partial or complete response to first-line chemotherapy. [5] The treatment starts with an infusion of rituximab.

7. Mantle cell lymphoma - Wikipedia

   en.wikipedia.org/wiki/Mantle_cell_lymphoma

   Mantle cell lymphoma (MCL) is a type of non-Hodgkin's lymphoma, comprising about 6% of cases. [1] [2] It is named for the mantle zone of the lymph nodes where it develops.[3] [4] The term 'mantle cell lymphoma' was first adopted by Raffeld and Jaffe in 1991.